CompoAtlas

Doctor's Choice For Diabetics

Withdrawn from the US market on 10 August 2023 (according to the DSLD)

Enzymatic Therapy, food supplement from the US market

Label withdrawn from the US market. Doctor's Choice For Diabetics (Enzymatic Therapy), a food supplement au code-barres 763948001293, is described by its US market label. If sold in France, it would be subject to 5 points of French or European regulation, detailed below. Doses of folates are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Enzymatic Therapy
Barcode
763948001293
Form
Tablet
One serving
2 tablets
Servings
up to 2 servings per day
Other ingredients (in English, as written)
Cellulose, Modified Cellulose, Sodium Bicarbonate, Citric Acid, Stearic Acid, Magnesium Stearate, Vegetable Glycerin, Carnauba wax
Ingredient (as written, in English)CategoryPer serving
Total CarbohydratesCarbohydrate1 Gram(s)
Dietary FiberFibre1 Gram(s)
Vitamin CVitamin300 mg
Vitamin EVitamin100 UI
Vitamin B6Vitamin10 mg
Folic AcidVitamin400 µg
Vitamin B12Vitamin400 µg
BiotinVitamin1 mg
MagnesiumMineral100 mg
ZincMineral7.5 mg
SeleniumMineral50 µg
CopperMineral0.5 mg
ManganeseMineral3.5 mg
SodiumMineral15 mg
Bitter Melon Fruit Extract (Momordica charantia)Plant200 mg
Gymnema leaf extract (Gymnema sylvestre)Plant200 mg
Fenugreek seed extract (Trigonella foenum-graecum)Plant100 mg
Bilberry fruit extractPlant40 mg
Mixed BioflavonoidsOther substance25 mg
VanadiumMineral1.6 mg

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Fenugreek seed extract
    Read the warning, when it applies and the studies cited

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010; Mills et al. 2006; Hoffman 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
    • Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. An Evidence-Based Approach. New York (NY): Taylor and Francis; 2006.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 29 May 2026

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Enzymatic Therapy

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Doctor's Choice For Diabetics : étiquette retirée du marché américain (Enzymatic Therapy): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/763948001293-doctor-s-choice-for-diabetics-enzymatic-therapy, updated 10 August 2023.

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line